CD8A and Epstein-Barr virus infection: The integration of computational biology and structural modeling approaches to identify T cell receptor (TCR) antigen specificity groups and TCR features associated with virologic control (11, –, 16) would facilitate our understanding of how EBV-specific CD8 T cells control EBV replication and contribute to the development of a vaccine to prevent or immunotherapies to modify EBV infection (7, 8, 17).